Cargando…
The bioavailability of cytarabine in dogs with meningoencephalitis of unknown etiology through iontophoresis and rectal delivery
BACKGROUND: Cytarabine (CA) is used to treat dogs with meningoencephalitis of unknown etiology (MUE) by subcutaneous or intravenous administration. AIM: The objective was to investigate transdermal iontophoresis and rectal administration as alternative routes of CA delivery. METHODS: Two client-owne...
Autores principales: | Mancini, Shelby L., Early, Peter J., Pastina, Bethany O., Olby, Natasha J., Mariani, Christopher L., Munana, Karen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of Veterinary Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057209/ https://www.ncbi.nlm.nih.gov/pubmed/33898281 http://dx.doi.org/10.4314/ovj.v11i1.6 |
Ejemplares similares
-
Continuous rate infusion of midazolam as emergent treatment for seizures in dogs
por: Bray, Kathryn Y., et al.
Publicado: (2020) -
Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs
por: Yun, Taesik, et al.
Publicado: (2021) -
Risk factors associated with progressive myelomalacia in dogs with complete sensorimotor loss following intervertebral disc extrusion: a retrospective case-control study
por: Castel, Aude, et al.
Publicado: (2019) -
Clinical characteristics, breed differences, and quality of life in North American dogs with acute steroid‐responsive meningitis‐arteritis
por: Lau, Jeanie, et al.
Publicado: (2019) -
Clinical Characteristics of Dogs with Progressive Myelomalacia Following Acute Intervertebral Disc Extrusion
por: Castel, A., et al.
Publicado: (2017)